Nemus Bioscience Inc. | Income Statement
Fiscal year is January-December. All values USD Thousands.
2013
2014
2015
2016
2017
Sales/Revenue
339.90
-
-
-
-
Cost of Goods Sold (COGS) incl. D&A
297.40
1.90
10.00
14.90
8.00
Gross Income
42.50
1.90
10.00
14.90
8.00
SG&A Expense
49.80
2,729.80
4,307.20
4,455.70
3,851.20
EBIT
7.20
2,731.70
4,317.10
4,470.60
3,859.20
Unusual Expense
6.50
-
522.30
1,294.10
767.20
Non Operating Income/Expense
1.70
-
-
-
-
Interest Expense
2.20
-
-
-
0.70
Pretax Income
3.80
2,731.70
4,839.40
3,176.50
3,092.70
Income Tax
-
2.50
1.70
1.60
1.60
Consolidated Net Income
3.80
2,734.20
4,841.20
3,178.10
3,094.30
Net Income
3.80
2,734.20
4,841.20
3,178.10
3,094.30
Net Income After Extraordinaries
3.80
2,734.20
4,841.20
3,178.10
3,094.30
Net Income Available to Common
3.80
2,734.20
4,841.20
3,503.10
4,138.30
EPS (Basic)
0.00
0.27
0.29
0.18
0.15
Basic Shares Outstanding
7,361.30
10,291.80
16,938.30
18,947.40
27,906.10
EPS (Diluted)
0.00
0.27
0.29
0.18
0.15
Diluted Shares Outstanding
7,361.30
10,291.80
16,938.30
18,947.40
27,906.10
EBITDA
3.60
2,729.80
4,307.20
4,455.70
3,851.20
Non-Operating Interest Income
0.80
-
-
-
-
Preferred Dividends
-
-
-
325.00
1,044.00
About Nemus Bioscience
View Profile
